Decoding Market Dynamics: An Interview with Ashlee Vogenthaler, PRISM MarketView’s Markets Editor New York, May 01, 2024 – At PRISM MarketView we are proud to feature
Emerging companies harness advanced tech to innovate, launch new products, and adapt to inflation in consumer markets New York, N.Y., February 27, 2024 – PRISM
New York, N.Y., January 12, 2024 – In concert with Cervical Health Awareness Month, PRISM MarketView has added Verastem, Inc., a biopharmaceutical company focused on
New York, December 29, 2023 – 2023 was a year filled with significant developments in emerging stocks, featuring a wide range of topics from clinical
New York, December 28, 2023 – Microbot Medical Inc. (Nasdaq: MBOT) has completed its GLP pivotal pre-clinical study for the LIBERTY® Endovascular Robotic Surgical System. The study, adhering
New York, December 28, 2023 – Enveric Biosciences (NASDAQ: ENVB), a biotechnology company specializing in developing novel treatments for mental health disorders, has named EB-003 as the lead candidate
New York, December 27, 2023 – Milestone Scientific Inc. (NYSE:MLSS) has established itself in the field of biomedical technology with its focus on advanced injection
New York, December 22, 2023 – Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of
New York, December 22, 2023 – Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump in its share price this week. The new momentum is
New York, December 21, 2023 – In two weeks, 2023 will be history so consider this your reminder to start figuring out a resolution that
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
